BSE announces changes to Long Term ASM Framework effective October 24, 2025, including 8 new securities shortlisted, 2 securities moving out, and 1 security moving to higher stage.
Impact
Medium
Severity
Medium
Justification
Affects trading conditions for 11 securities through ASM framework changes, requiring market participants to adjust trading strategies for these scrips
BSE announces demat auction settlement no. 739 listing securities available for auction due to delivery shortages.
Impact
Medium
Severity
Medium
Justification
Routine demat auction for settlement 739 affecting multiple securities due to delivery shortages. Impacts specific trading members and clients with failed deliveries.
BSE announces demat auction for settlement number 739 covering securities from 140+ companies with specified quantities for auction settlement.
Impact
Medium
Severity
Medium
Justification
Routine demat auction affecting multiple securities with delivery defaults; impacts specific brokers and their clients who failed to deliver securities in settlement 739
BSE Demat Auction settlement listing 139 securities across various scrips for settlement number 739 dated October 23, 2025.
Impact
Medium
Severity
Medium
Justification
Regular demat auction settlement affecting multiple securities with specific quantities to be auctioned. Important for brokers and clearing members involved in settlement obligations but routine market operation.
BSE revises price bands for 10 securities including Chartered Capital & Investment Ltd, Envair Electrodyne Ltd, and others, effective from October 21, 2025.
Impact
Medium
Severity
Medium
Justification
Affects trading parameters for 10 scrips with varying price band adjustments, impacting daily price movement limits and trading dynamics for these securities
SEBI grants exemption to Nureca Limited from strict enforcement of regulation 24(ii) of Buy-back Regulations, 2018 in connection with merger of wholly owned subsidiary Nureca Technologies Private Limited.
Impact
Low
Severity
Low
Justification
Company-specific exemption for internal restructuring involving merger of wholly owned subsidiary with no impact on public shareholding or market operations.